Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties

被引:58
作者
Chessa, Elisabetta [1 ,2 ]
Piga, Matteo [1 ,2 ]
Floris, Alberto [1 ,2 ]
Devilliers, Herve [3 ,4 ]
Cauli, Alberto [1 ,2 ]
Arnaud, Laurent [5 ,6 ]
机构
[1] AOU Univ Clin, Rheumatol Unit, Cagliari, Italy
[2] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy
[3] CHU Dijon, Serv Med Interne & Malad Syst Med Interne, Hop Francois Mitterrand, Dijon, France
[4] Inserm CIC EC 1432, Ctr Invest Clin, Dijon, France
[5] Univ Strasbourg, Hop Univ Strasbourg, Serv Rhumatol, Strasbourg, France
[6] Ctr Natl Reference Malad Syst & Autoimmunes Rares, Strasbourg, France
关键词
systemic lupus erythematosus; disease activity; physician global assessment; PGA; psychometrics; CROSS-CULTURAL VALIDATION; DISEASE-ACTIVITY INDEX; ERYTHROCYTE SEDIMENTATION-RATE; QUALITY-OF-LIFE; IMPACT TRACKER; ORGAN DAMAGE; IMPORTANT DIFFERENCE; CAUCASIAN PATIENTS; CHINESE PATIENTS; CORONARY PLAQUE;
D O I
10.1093/rheumatology/keaa383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The Physician Global Assessment (PGA) is a visual analogue score that reflects the clinician's judgement of overall SLE disease activity. The aim of this systematic literature review is to describe and analyse the psychometric properties of the PGA. Methods. This systematic literature review was conducted by two independent reviewers in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. All articles published through 1 July 2019 in PubMed were screened, with no limitation on year of publication, language or patients' age. Psychometric properties data were analysed according to the OMERACT Filter methodology version 2.1. Results. The literature search identified 91 studies. Face validity was reported in all the articles retrieved in which the PGA was used alone or as part of composite indices (Systemic Responder Index, Safety of Estrogen in Lupus Erythematosus National Assessment Flare Index, Lupus Low Disease Activity State, Definitions of Remission in Systemic Lupus Erythematosus criteria). Content validity was reported in 89 studies. Construct validity was demonstrated by a good correlation (r >= 0.50) between the PGA with the SLEDAI (12 studies), SLAM (4 studies), LAI, BILAG and ECLAM (2 studies each). Criterion validity was assessed exploring the PGA correlation with quality of life measurements, biomarker levels and treatment changes in 28 studies, while no study has evaluated correlation with damage. A good responsiveness for PGA was shown in eight studies. A high variability in scales was found, causing a wide range of reliability (intraclass correlation coefficient 0.67-0.98). Conclusion. PGA is a valid, responsive and feasible instrument, though its reliability was impacted by the scale adopted, suggesting the major need for standardization of its scoring.
引用
收藏
页码:3622 / 3632
页数:11
相关论文
共 115 条
[1]   Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers [J].
Akhter, E. ;
Burlingame, R. W. ;
Seaman, A. L. ;
Magder, L. ;
Petri, M. .
LUPUS, 2011, 20 (12) :1267-1274
[2]   Psychometric properties of MDHAQ/RAPID3 in patients with systemic lupus erythematosus [J].
Annapureddy, N. ;
Giangreco, D. ;
Devilliers, H. ;
Block, J. A. ;
Jolly, M. .
LUPUS, 2018, 27 (06) :982-990
[3]   Validation of the Lupus Impact Tracker in an Australian patient cohort [J].
Antony, A. ;
Kandane-Rathnayake, R. K. ;
Ko, T. ;
Boulos, D. ;
Hoi, A. Y. ;
Jolly, M. ;
Morand, E. F. .
LUPUS, 2017, 26 (01) :98-105
[4]   Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLE [J].
Aranow, Cynthia ;
Askanase, Anca ;
Oon, Shereen ;
Huq, Molla ;
Calderone, Alicia ;
Morand, Eric F. ;
Nikpour, Mandana .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) :787-792
[5]   A pilot study to determine the optimal timing of the Physician Global Assessment (PGA) in patients with systemic lupus erythematosus [J].
Aranow, Cynthia .
IMMUNOLOGIC RESEARCH, 2015, 63 (1-3) :167-169
[6]   Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus [J].
Arriens, Cristina ;
Hynan, Linda S. ;
Lerman, Robert H. ;
Karp, David R. ;
Mohan, Chandra .
NUTRITION JOURNAL, 2015, 14
[7]   Preliminary test of the LFA rapid evaluation of activity in lupus (LFA-REAL): an efficient outcome measure correlates with validated instruments [J].
Askanase, Anca ;
Li, Xiaoqing ;
Pong, Avery ;
Shum, Katrina ;
Kamp, Stan ;
Carthen, Fredonna ;
Aberle, Teresa ;
Hanrahan, Leslie ;
Daly, Paola ;
Giles, Jon ;
Merrill, Joan T. .
LUPUS SCIENCE & MEDICINE, 2015, 2 (01)
[8]   Comparison of the Lupus Foundation of America-Rapid Evaluation of Activity in Lupus to More Complex Disease Activity Instruments As Evaluated by Clinical Investigators or Real-World Clinicians [J].
Askanase, Anca D. ;
Nguyen, Samantha C. ;
Costenbader, Karen ;
Lim, S. Sam ;
Kamen, Diane ;
Aranow, Cynthia ;
Grossman, Jennifer ;
Kapoor, Teja M. ;
Baker-Frost, DeAnna ;
Aberle, Teresa ;
Thanou-Stavraki, Aikaterini ;
Hanrahan, Leslie M. ;
Kim, Mimi ;
Merrill, Joan T. .
ARTHRITIS CARE & RESEARCH, 2018, 70 (07) :1058-1063
[9]  
Barr SG, 1999, ARTHRITIS RHEUM, V42, P2682, DOI 10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO
[10]  
2-6